Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cu-medicine-develops-a-probiotic-formula-to-target-imbalance-in-gut-microbiota-in-covid-19
https://www.med.cuhk.edu.hk/press-releases/cu-medicine-develops-a-probiotic-formula-to-target-imbalance-in-gut-microbiota-in-covid-19

CU Medicine Develops a Probiotic Formula to Target Imbalance in Gut Microbiota in COVID-19

Have you ever thought about why some people are more vulnerable to catching a virus? And why some get more severe infection than others? Gut microbiota, which is a fine balance between good and bad bacteria, regulates our immune system. Imbalance in gut microbiota (dysbiosis) will make us susceptible to infections.  

 

Before the role of gut microbiota in COVID-19 was identified, the National Health Commission of the People's Republic of China had already included the use of probiotics for treatment of COVID-19 in January 2020. However, currently available probiotic products have many limitations. For example, many probiotic bacteria are susceptible to gastric acid, high temperature and humidity. The shelf-life of many probiotic products is short. On top of that, not all kinds of probiotics can help enhance our immunity. To date, there is an urgent unmet need to define the role of gut microbiota in COVID-19. 

 

The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) is the first to discover a series of good bacteria missing in the gut of COVID-19 patients. The research team confirmed this discovery with a large number of healthy subjects and COVID-19 patients. Using big data analysis and machine learning, the research team has successfully developed a probiotic formula that aims to target gut dysbiosis, thereby offering hope of boosting immunity against COVID-19 and other emerging viral infections. They anticipate that the formula will soon be turned into a probiotic supplement to go with our daily diet to improve our defence against infection.

 

COVID-19

CU Medicine is the first to discover a series of good bacteria missing in the gut of COVID-19 patients. The research team confirmed this discovery with a large number of healthy subjects and COVID-19 patients. Using metagenomics and big data analysis, the research team has successfully developed a probiotic formula that aims to target gut dysbiosis. (From right) Prof. Francis CHAN, Dean of CU Medicine and Director of the Centre for Gut Microbiota Research;  Prof. Paul CHAN, Chairman of the Department of Microbiology; and Prof. Siew NG, Associate Director of the Centre for Gut Microbiota Research at CUHK.

Professor Francis KL CHAN, Dean of CU Medicine and Director of the Centre for Gut Microbiota Research at CUHK, remarked, “Gut health rules over the immune system of our bodies. We must identify the composition of intestinal bacteria that helps maintain our defense. From there on, we can modulate the gut microbiota to boost our immunity against viral and bacterial infections. This will be a novel approach in the combat of COVID-19.”    

 

What is Gut Microbiota?

 

Gut microbiota refers to the microbe population living in our intestine. Our gut microbiota contains tens of trillions of microorganisms, including at least 1,000 different species of known bacteria with more than 3 million genes (150 times more than human genes).  Gut microbiota is as significant to our health as an organ and plays an important role in our immunity. Gut dysbiosis will make us susceptible to infections.  

 

In the latest research published in the international medical journal Gastroenterology,CU Medicine investigated the alteration of gut microbiota in local COVID-19 patients. From February to March this year, stool specimens were collected from 15 COVID-19 patients whose conditions ranged from mild to critically ill from the time of hospitalisation until discharge.  The research team studied the microorganisms present in the patients’ guts and compared them with those from healthy individuals.

 

Professor Paul Kay Sheung CHAN, Chairman of the Department of Microbiology at CU Medicine and Associate Director of the Centre for Gut Microbiota Research at CUHK, said, “This is the first study in the world to realise that severe gut dysbiosis exists in COVID-19 patients.  Some commensal symbionts, generally good bacteria, were missing while other pathogens were increasing in the patients’ guts. The condition prevailed even after patients had been discharged.”

 

prof francis chan

Prof. Francis Chan (left) states that gut health rules over the immune system of our bodies. Through identifying the composition of intestinal bacteria that helps maintain our defence, the gut microbiota can be modulated to boost our immunity against viral and bacterial infections. This will be a novel approach in the combat of COVID-19.

 

prof siew ng

Prof. Siew Ng remarks the CU Medicine’s probiotic formula is derived from gut microbiota data from the Chinese population. The research team is studying good bacteria that are closely linked to human’s immune system with the hope to boost the immunity.

prof paul chan
Prof. Paul Chan says that the recent study of CU Medicine is the first in the world to discover that severe gut dysbiosis exists in COVID-19 patients. Some commensal symbionts, generally good bacteria, were missing while other pathogens were increasing in the patients’ guts.

The research team further expanded the research scope and collected data on gut microbiome of 150 COVID-19 patients and 1,500 healthy individuals. With the use of big data analysis, the team managed to come up with a probiotic formula which targets at gut dysbiosis derived from COVID-19 infections. The CU Medicine team carefully calculated the proportion of good bacteria and came up with a processing protocol which helps enhance the stability and quantity of live bacteria.    

 

Patents Applied for the Innovation and More Researches for Further Scientific Reference

 

Professor Siew Chien NG, Associate Director of the Centre for Gut Microbiota Research at CUHK, explained, “The composition of microorganisms in our gut can be altered by diet or lifestyle.  What appears to be useful in the West may not be as beneficial among Asian populations. This study provides a whole new perspective in the fight against COVID-19. Our probiotic formula is derived from data from the Chinese population. We are studying good bacteria that are closely linked to our immune system and looking for solutions to limit the threat of the novel coronavirus to our health.”

 

COVID-19

The CU Medicine research team anticipates that a probiotic supplement will be produced that could be added into daily diet to enhance the gut health. 

 

CU Medicine has applied for patents for the probiotic innovation in China and the U.S. and is now collaborating with innovation and technology companies and food companies to turn the formula into a probiotic supplement that can be added into the daily diet. The team is hopeful that the innovation can soon reach the public to enhance gut health. They are now working on large-scale clinical trials to provide further scientific evidence on the importance of gut health in preventing any novel infectious diseases. One of the research projects is supported by the Health and Medical Research Fund of the HKSAR government.     

 

More Press Releases

CU Medicine Study Shows Modulation of Gut Microbiota  Helps Enhance Safety and Efficacy of COVID-19 Vaccine

CU Medicine Study Shows Modulation of Gut Microbiota Helps Enhance Safety and Efficacy of COVID-19 Vaccine

Research
CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

CU Medicine Finds New Evidence for Link between Gut Microbiome and COVID-19 Severity Microbiome Imbalance Might Influence “Long COVID” Risk

Research
A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

A randomised placebo-controlled clinical trial by CU Medicine shows that modulation of gut microbiome using oral microencapsulated live bacteria (SIM01) improves long COVID symptoms

Research
CU Medicine Study Suggests Toddlers are at High Risk of Being  “Silent Spreaders of SARS-CoV2 Infection”

CU Medicine Study Suggests Toddlers are at High Risk of Being “Silent Spreaders of SARS-CoV2 Infection”

Research
40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

40% of Hong Kong People Show Gut Dysbiosis Comparable to that of COVID-19 Patients CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity

Research
CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

CU Medicine Found SARS-CoV2 in Infants' Stool A Coronavirus Testing Centre Is Established for Paediatric Population to Identify Silent Carriers

Research
The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

The Helmsley Charitable Trust Funds Asian Research into Babies’ Gut Microbiota and Crohn’s Disease

Research
CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

CU Medicine leads new clinical practice guidelines on use of non-invasive biomarkers for colorectal cancer screening with international experts

Research
CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

CU Medicine’s population-based long COVID-19 survey estimates that over 400,000 recovered COVID-19 patients suffer from sexual dysfunction and reproductive problems

Research
CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

CU Medicine supported by the Hospital Authority to launch HK’s first large-scale Long COVID survey, aiming to inform the government on impact of long COVID on healthcare services

Research
CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long COVID

Research
CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers  with Sensitivity Over 90%

CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90%

Research
CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

CU Medicine Offers Free Stool Screening Test for COVID-19 in Children arriving at Airport

Clinical service
CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

CUHK Finds that the Coronavirus Can Persist in Stool after Its Clearance in Respiratory Tract Will Conduct Stool Test for People in Quarantine Camps for Early Identification

Research
CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

CUHK Establishes Asia’s First Microbiota Transplantation and Research Centre Hope for New Strategies in Disease Prevention and Cure

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CUHK proves its self-developed oral microencapsulated live bacteria formula SIM03 improves disease severity and quality of life in children with eczema

CUHK proves its self-developed oral microencapsulated live bacteria formula SIM03 improves disease severity and quality of life in children with eczema

Research
CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms

Research
CU Medicine discovers gut microbiome and metabolome markers that predict long-term COVID-19 vaccine effectiveness

CU Medicine discovers gut microbiome and metabolome markers that predict long-term COVID-19 vaccine effectiveness

Research
CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

CUHK conducts interdisciplinary study on gut microbiota in pregnancy to reduce risk of inflammatory bowel disease in babies

Research
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19

Research
CU Medicine study shows distinct gut microbial profile associated with long COVID

CU Medicine study shows distinct gut microbial profile associated with long COVID

Research
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis

Research
CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

CU Medicine Survey Shows Only 25% of Unvaccinated People Intend to Get Inoculated in the Coming Six Months “Multiple Incentives” are Urgently Needed

Research
CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong  All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses  Urgent Call for the Largely Unprotected Population to Get Vaccinated

CU Medicine Estimates 20,000 COVID-19 Hidden Infections in Hong Kong All Vaccinated Persons in HK Developed Neutralising Antibody After Two Doses Urgent Call for the Largely Unprotected Population to Get Vaccinated

Research
CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

CU Medicine Receives USD 2 Million from The Helmsley Charitable Trust to Partner with University of Calgary to Create a Global Repository on the Epidemiology of Crohn's Disease

Research
CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

CU Medicine Survey Shows Government Recommendation as the Strongest Driver for COVID-19 Vaccine Acceptance

Research
CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

CU Medicine Recruits 3,000 Persons to Investigate Hidden Infection and Break the Obstacles in Containing COVID-19 in Hong Kong

Research
Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Awards and honors
CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

CUHK Announces World’s First Meta-analysis on Prevalence of Helicobacter pylori Infection

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

CUHK World’s First Study Sets a New Direction on Aspirin Use after Lower Gastrointestinal Hemorrhage

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

CUHK Latest Research Reveals FMT Effectiveness Triples that of Conventional Treatment

Research
Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Hong Kong and Macau Among Top Three Regions in Asia-Pacific with the Highest Incidence of Inflammatory Bowel Disease CUHK Establishes Registry to Increase Public Awareness

Research
CU Medicine finds from free-text narratives that COVID-19 symptoms change with virus mutations and vaccination status, and demonstrates AI large language models contribute to infectious disease research

CU Medicine finds from free-text narratives that COVID-19 symptoms change with virus mutations and vaccination status, and demonstrates AI large language models contribute to infectious disease research

Research
CU Medicine finds benign prostatic hyperplasia patients suffer from up to five times the risk of urological complications after COVID-19 infection

CU Medicine finds benign prostatic hyperplasia patients suffer from up to five times the risk of urological complications after COVID-19 infection

Research
CUHK study estimates half of COVID-19 infections went unrecognised during the Omicron epidemic in Hong Kong

CUHK study estimates half of COVID-19 infections went unrecognised during the Omicron epidemic in Hong Kong

Research
CU Medicine develops novel microbiome technology MOZAIC for faecal microbiota transplantation; Enhancing treatment success for Clostridioides difficile infections to over 90%

CU Medicine develops novel microbiome technology MOZAIC for faecal microbiota transplantation; Enhancing treatment success for Clostridioides difficile infections to over 90%

Research
CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong  to be selected as a New Cornerstone Investigator

CUHK Professor Siew Ng becomes the first clinician-scientist in Hong Kong to be selected as a New Cornerstone Investigator

Awards and honors
CUHK receives HK$30 million donation from Mr Li Ka-shing to further enhance artificial intelligence in medical education

CUHK receives HK$30 million donation from Mr Li Ka-shing to further enhance artificial intelligence in medical education

Donation
CUHK study reveals prevalence of myopia in children has reached record high in Hong Kong Number of myopic children aged six is double after COVID-19 restrictions Low-concentration atropine eyedrops with red light therapy study launched

CUHK study reveals prevalence of myopia in children has reached record high in Hong Kong Number of myopic children aged six is double after COVID-19 restrictions Low-concentration atropine eyedrops with red light therapy study launched

Research
CUHK-PWH research confirms Paxlovid can benefit patients with severe kidney disease

CUHK-PWH research confirms Paxlovid can benefit patients with severe kidney disease

Research
Joint Study Unveils How COVID-19  Adversely Impacts Placenta During Pregnancy

Joint Study Unveils How COVID-19 Adversely Impacts Placenta During Pregnancy

Research
CU Medicine establishes an internationally accredited biobank:  A prerequisite for Hong Kong to be the hub for new drug development in the Greater Bay Area

CU Medicine establishes an internationally accredited biobank: A prerequisite for Hong Kong to be the hub for new drug development in the Greater Bay Area

Milestone
CUHK discovers the occurrence of gut microbiome dysbiosis at the prodromal stages of Parkinson’s disease Gives novel insights into neurodegenerative prevention, intervention and diagnosis

CUHK discovers the occurrence of gut microbiome dysbiosis at the prodromal stages of Parkinson’s disease Gives novel insights into neurodegenerative prevention, intervention and diagnosis

Research
T-cell responses elicited by COVID-19 vaccines Comirnaty and CoronaVac provide effective protection against severe disease from different SARS-CoV-2 variants

T-cell responses elicited by COVID-19 vaccines Comirnaty and CoronaVac provide effective protection against severe disease from different SARS-CoV-2 variants

Research
CUHK’s study sees small intestinal cancer incidence rising globally and in Hong Kong Higher incidence observed in high-income countries

CUHK’s study sees small intestinal cancer incidence rising globally and in Hong Kong Higher incidence observed in high-income countries

Research
CU Medicine proves oral antivirals for COVID-19 can lower the risk of hospitalisation and  inpatient progression in older patients living in nursing homes

CU Medicine proves oral antivirals for COVID-19 can lower the risk of hospitalisation and inpatient progression in older patients living in nursing homes

Research
CUHK finds high intention in Hong Kong to keep wearing masks and using alcohol-based sanitiser but low intention to receive a booster shot in the current era of COVID-19 endemicity

CUHK finds high intention in Hong Kong to keep wearing masks and using alcohol-based sanitiser but low intention to receive a booster shot in the current era of COVID-19 endemicity

Research
Inaugural Croucher Professorship in Medical Science lecture by Professor Siew Ng:   A Magical Pursuit

Inaugural Croucher Professorship in Medical Science lecture by Professor Siew Ng: A Magical Pursuit

Awards and honors
CU Medicine, MagIC and HKSTP join hands to organise the Microbiome Summit 2023 “Hong Kong as a regional hub for microbiome industry”

CU Medicine, MagIC and HKSTP join hands to organise the Microbiome Summit 2023 “Hong Kong as a regional hub for microbiome industry”

Symposium
A joint HKU-CUHK study confirms smoking and obesity increase  risk of severe COVID-19 by 65%-81%

A joint HKU-CUHK study confirms smoking and obesity increase risk of severe COVID-19 by 65%-81%

Research
中大醫學院就行政長官今日(10月19日)發表2022施政報告的回應 (Chinese Version Only)

中大醫學院就行政長官今日(10月19日)發表2022施政報告的回應 (Chinese Version Only)

Response
CUHK study advises residential care homes for the elderly to maintain current infection control practices

CUHK study advises residential care homes for the elderly to maintain current infection control practices

Research
CUHK-HKU collaborative study finds about 80% lower risk of death among COVID-19 inpatients prescribed oral medication and the risk of hospital admission in outpatients is significantly reduced by nearly 90%

CUHK-HKU collaborative study finds about 80% lower risk of death among COVID-19 inpatients prescribed oral medication and the risk of hospital admission in outpatients is significantly reduced by nearly 90%

Research
CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

CUHK develops a real-time bioinformatics platform to predict COVID-19 vaccine effectiveness against SARS-CoV-2 variants with 95% accuracy

Research
COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

COVID-19 pandemic disrupted the daily lives of schoolchildren in Hong Kong; Proportion of overweight and obese kids more than doubled

Research
CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

CUHK receives HK$150 million donation from Li Ka Shing Foundation in support of research and development of biomedical technologies

Donation
CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

CUHK finds that a booster vaccine dose is effective in retriggering antibodies in breast milk that protect babies

Research
CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

CUHK study suggests COVID-19 booster shot is key to protecting against infection among high-risk populations and from variants of concern

Research
HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

HKUMed-CU Medicine joint study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection

Research
CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

CUHK Clinical Trial Centre collaborates with CUHK Medical Centre to conduct Hong Kong’s first clinical trial of novel oral treatment specifically developed for COVID-19

Research
CU Medicine study shows a higher prevalence of dry eye disease  among post-COVID-19 patients

CU Medicine study shows a higher prevalence of dry eye disease among post-COVID-19 patients

Research
CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

CU Medicine and Kowloon City District Office co-organise community COVID-19 vaccination programme targeting 2,000 residents, especially young children

Health Campaign
A joint HKU-CUHK study finds that smoking  increases the risk of COVID-19

A joint HKU-CUHK study finds that smoking increases the risk of COVID-19

Research
中大醫學院就2022-23財政預算案的回應 (Chinese Version Only)

中大醫學院就2022-23財政預算案的回應 (Chinese Version Only)

Response
CUHK-HKU collaborative research finds a new inflammatory activation pathway in  blood vessels after SARS-CoV-2 infection

CUHK-HKU collaborative research finds a new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection

Research
Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Assessment of Omicron outbreak in Hong Kong after reimplementation of some of the toughest social distancing measures effective from 7 January

Research
HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron

Research
HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

HKUMed-CU Medicine joint study finds COVID-19 variant Omicron significantly reduces virus neutralisation ability of BioNTech vaccine

Research
CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

CUHK study sheds light on novel mechanism and treatment of acute kidney injury in COVID-19 patients

Research
CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise  Performance of COVID-19 Nucleic Acid Tests

CUHK Study Suggests a Standardised Experimental Setup is the Key to Optimise Performance of COVID-19 Nucleic Acid Tests

Research
Clarification -- 中大醫學院澄清啟事 (Chinese Version Only)

Clarification -- 中大醫學院澄清啟事 (Chinese Version Only)

Response
CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children  During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

CUHK Study Demonstrates a 2.5-fold Increase in Myopia Incidence in Children During COVID-19 Pandemic Due to Less Time Outdoors and More Time on Screens

Research
CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and  Identifies Faecal Bacterial Markers for Autism

CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism

Research
CUHK and Hong Kong Association of Careers Masters and Guidance Masters Survey Shows Concerns about Hong Kong Students Suffering from Irritable Bowel Syndrome

CUHK and Hong Kong Association of Careers Masters and Guidance Masters Survey Shows Concerns about Hong Kong Students Suffering from Irritable Bowel Syndrome

Research
A Global Study Led by CU Medicine and HKUMed Discovers  a Hepatitis C Virus Drug as Potent Treatment for COVID-19

A Global Study Led by CU Medicine and HKUMed Discovers a Hepatitis C Virus Drug as Potent Treatment for COVID-19

Research
CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

CU Medicine Study Shows Recovered Mothers Transfer COVID-19 Antibodies to Newborn Babies

Research
CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

CU Medicine and International Surgeons Suggest Patients with Positive COVID-19 Results Should Delay Surgery for Seven Weeks to Reduce Death Risk

International collaboration
CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

CUHK Introduces Nasal Strip Sampling for COVID-19 Test As a Superior Tool for Surveillance in a Wide Age-Range Population

Research
CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

CUHK Study Shows Exposure Settings Impact COVID-19 Transmission With Entertainment Setting Showing Propensity for Widespread Dispersion

Research
CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

CU Medicine Finds An Increasing Global Trend on Pancreatic Cancer among Female and Younger Individuals

Research
Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Most Deaths from COVID-19 in Hong Kong are of 60 Years Old or Above CUHK Initiated International Effort in Devising Strategies to Protect Older People with Dementia amid COVID-19 Pandemic

Research
CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

CU Medicine Study Shows Liver Injury is Common and Prognostic in COVID-19 Patients

Research
CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19,  and Possible Mechanisms

CUHK Researchers Uncover Diabetes as a Potential Risk Factor for COVID-19, and Possible Mechanisms

Research
CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

Research
CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

CU Medicine Announces the Community Response Study Results During the Early Phase of the COVID-19 Outbreak in Hong Kong

Research
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

CUHK Study Proves Low-Dose Tricyclic Antidepressant (TCA) Effective in Treating Patients with Refractory Functional Dyspepsia

Research
CUHK-Designed Intervention Package Proves Effective to Increase Influenza Vaccine Uptake in Hong Kong Young Children

CUHK-Designed Intervention Package Proves Effective to Increase Influenza Vaccine Uptake in Hong Kong Young Children

Research
CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

CUHK Establishes Hong Kong Hub of Paediatric Excellence (HK HOPE) Multidisciplinary Efforts Across the Globe to Advance Children’s Health and Well-being

Health Campaign
CUHK Reveals the Key to a Successful HPV Vaccination Programme

CUHK Reveals the Key to a Successful HPV Vaccination Programme

Research
CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

CUHK Pioneers in Introducing Museum-Based Observational Skills into Medical Education

Education
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

International collaboration
CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

International collaboration
CUHK Proves Rotavirus Vaccine Highly Effective for HK Children

CUHK Proves Rotavirus Vaccine Highly Effective for HK Children

Research
CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

CUHK Research Shows 1 in 5 Throat Cancer Patients in HK is HPV infected

Research
CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

CUHK Conducts Hong Kong’s First Study on Seven Common Respiratory Viruses Revealing Respiratory Syncytial Virus and Influenza A as Prevalent Fatal Types

Research
CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

CUHK Reveals Hepatitis B Prevalence Among Pregnant Women Remains High Despite More Than 25 Years of Universal Hepatitis B Vaccination

Research
CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

CUHK Succeeds in Treating Gastroesophageal Reflux Disease by Implantable Pulse Generator

Surgical advancement
CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

Research
CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

CUHK Conducts Asia's Largest Clinical Study on Life-threatening Infections caused by RSV and Influenza in Hong Kong Adults and Elderly

Research
CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

Research
CUHK Research Reveals New Influenza Vaccine Offers More Effective Control over Influenza in Hong Kong

CUHK Research Reveals New Influenza Vaccine Offers More Effective Control over Influenza in Hong Kong

Research
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

Research
CUHK Introduces Double Balloon Enteroscopy Service to Manage Small Bowel Diseases

CUHK Introduces Double Balloon Enteroscopy Service to Manage Small Bowel Diseases

Clinical service
Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Predicting Your Colorectal-polyp Risk with CUHK Colorectal-polyp Prediction Index (CU-CPI)

Clinical service
CUHK Research Findings on Severe Human Swine Flu in Hong Kong

CUHK Research Findings on Severe Human Swine Flu in Hong Kong

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.